BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5067927)

  • 1. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoxazolecarboxamidoalkylbenzolesulfonylurea, -semicarbazide and -aminopyrimidine as well as related compounds and their blood sugar reducing activity].
    Plümpe H; Horstmann H; Puls W
    Arzneimittelforschung; 1974 Mar; 24(0):363-74. PubMed ID: 4408067
    [No Abstract]   [Full Text] [Related]  

  • 3. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 4. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acylaminoalkylbenzolsulfonylsemicarbazides as blood sugar decreasing substances].
    Aumüller W; Fauland E; Hagedorn A; Heerdt R; Hübner M; Muth K; Weber H; Weyer R; Bänder A; Pfaff W; Schmidt FH; Stork H
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1350-4. PubMed ID: 5394453
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 8. [N1-aryl-N1-alkyl(or acetamido)-N4-arylsulfonyl-semicarbazides of potential hypoglycemic activity].
    Brancaccio G; Lettieri G; Larizza A; Monforte P
    Boll Chim Farm; 1979 May; 118(5):261-5. PubMed ID: 454545
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles.
    Soliman R; Mokhtar H; Mohamed HF
    J Pharm Sci; 1983 Sep; 72(9):999-1004. PubMed ID: 6631713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,4,5-trisubstituted pyrazoles.
    Soliman R; Mokhtar H; Mohamed HF
    J Pharm Sci; 1983 Sep; 72(9):1004-7. PubMed ID: 6631680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM; El Sadany SK; Mohamed HF
    J Pharm Sci; 1981 Jun; 70(6):606-10. PubMed ID: 6788935
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles.
    Soliman R
    J Med Chem; 1979 Mar; 22(3):321-5. PubMed ID: 423216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemic compounds. Sulfanilylurea derivatives containing amino acids and dipeptides. I.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Aug; 38(8):595-602. PubMed ID: 6617854
    [No Abstract]   [Full Text] [Related]  

  • 20. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.